Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
analyzed, biomarker, decision, discontinuation, discontinue, discontinued, discontinuing, explore, feasibility, inflammatory, low, mast, mg, serum, tryptase, urticaria, vendor, workforce
Removed:
advanced, characterized, designation, determining, developed, disease, escalation, expansion, greater, oncogenic, orphan, type
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view